New treatments for movement disorders?

Trends in Pharmacological Sciences

Volumn 17, Issue 10, 1996, Pages 339-342

  Fox, Susan H ^a   Brotchie, Jonathan M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; REMACEMIDE; ROPINIROLE; SELEGILINE; U 91356A; UBIDECARENONE; UNCLASSIFIED DRUG;

ANIMAL MODEL; CLINICAL TRIAL; CONFERENCE PAPER; DYSKINESIA; HUMAN; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0030273362     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(96)30018-7     Document Type: Conference Paper

References (1)

1. 1 Lees, A. J. et al. (1995) Br. Med. J. 311, 1602-1607